Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Stop Digging for Data: Uncover Productivity Issues and Opportunities in Minutes

Sterile Processing Departments (SPDs), as with all other industries in healthcare, are struggling with supply chain concerns, a lack of steady commitment from staff, and a workforce shortage. Additionally, SPDs have long dealt with issues in staffing shortages, which even extends to how facilities maximize their spaces. Seamus Johnson, Senior Director of Application Development…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Promoted content from Censis on MarketScale.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

Sterile Processing Departments (SPDs), as with all other industries in healthcare, are struggling with supply chain concerns, a lack of steady commitment from staff, and a workforce shortage. Additionally, SPDs have long dealt with issues in staffing shortages, which even extends to how facilities maximize their spaces. Seamus Johnson, Senior Director of Application Development at Censis Technologies, and Barry Phetteplace, Chief Technology Officer at Censis Technologies, spoke with Tyler Kern about these issues and how powerful data analytics tools like CensisAI2 Productivity can help combat these challenges. 

Understanding resource utilization and where the gaps lie is fundamental to creating the efficiencies required to get the job done when workers are in short supply. 

“Until you’ve delved into that data and really understand, a lot of times it’s guesswork,” Phetteplace said. “If you’re a small SPD where you only have a few techs, maybe it’s a little easier, but if you’re a large facility or a large IDN with multiple facilities, it becomes that much more difficult.” 

Johnson said there are several levels of data that perioperative and sterile processing leaders want, and need visibility over their operative needs. “At the high level, what’s important is being able to see everything your department’s doing, seeing what your throughput is in terms of how many trays you’re able to process for the OR. That’s your capacity to support the cases and patients.” 

Having data is one thing; accessing it and making sense of it is another. Creating cumbersome pivot tables can take hours to get the data into usable shape. It isn’t typically something a person running a sterile processing department wants to spend their valuable time doing. Phetteplace said Censis understands these challenges. Censis designed CensisAI2 Productivity to provide a faster way to analyze data. “We want to understand if we’re winning or losing. That was the mantra we had going into this, understanding the concept of productivity. It shouldn’t take me fifteen minutes to dig through tab after tab and look at complicated charts and graphs to understand if I’m winning or losing.” 

Interested in learning more about Censis Technologies’ surgical asset management platform? Visit Censis.com.

Censis

Part of this channel

Censis

Surgical instrument management software for over 1,300 U.S. hospitals.

Visit the channel

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Microsoft’s 60% Dragon Copilot discount forces a new way to measure digital health ROI

Microsoft’s 60% Dragon Copilot discount forces a new way to measure digital health ROI

Microsoft has introduced a 60% discount for its Dragon Copilot, prompting a reevaluation of how digital health ROI is measured. The initiative targets rural hospitals, while European efforts like EDiHTA highlight the need for a consistent method to price technology evidence. This shift reflects a broader trend in healthcare towards data-driven decision-making and cost assessment.

  • 01Microsoft offers a 60% discount for Dragon Copilot aimed at rural hospitals.
  • 02There's a growing need for a standardized approach to pricing technology evidence in healthcare.
  • 03The European EDiHTA initiative exemplifies the trend of data-driven evaluation in digital health.

Aug 30, 2026

Tarsus’ $450M Alkeus deal puts phase 3 retina programs on the same integration plan

Tarsus’ $450M Alkeus deal puts phase 3 retina programs on the same integration plan

Tarsus has made a $450 million deal with Alkeus to acquire two assets, including a phase 3 oral Stargardt program and a post-injection antiseptic. The focus now moves to clinical trial operations, chemistry manufacturing and controls, and plans for specialty distribution. These acquisitions aim to expand Tarsus' retina programs.

  • 01Tarsus acquired a phase 3 oral Stargardt asset and a post-injection antiseptic for $450 million.
  • 02The acquisitions focus on enhancing clinical trial operations and chemistry manufacturing controls.
  • 03Plans for future specialty distribution of the acquired assets are in place.

Aug 29, 2026

FDA’s Oct. 19 AI docket forces medtech teams to write tests, not slide decks

FDA’s Oct. 19 AI docket forces medtech teams to write tests, not slide decks

The FDA has released a generative AI discussion paper proposing a shift towards competency-style evaluation and increased postmarket monitoring in the healthcare industry. This move may lead vendors and hospital buyers to prioritize developing robust testing protocols for AI applications. The focus is on ensuring reliable and safe AI implementation in medical technologies.

  • 01The FDA's discussion paper suggests implementing competency-style evaluation for AI in healthcare.
  • 02There is an emphasis on increased postmarket monitoring for AI applications in the medical field.
  • 03Vendors and hospital buyers are encouraged to focus on developing testing protocols rather than presentations.

Aug 29, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512